Menu Search
Equities

Evolent Health Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
9EH:STU

Evolent Health Inc

Actions
  • Price (EUR)2.40
  • Today's Change-0.06 / -2.44%
  • Shares traded0.00
  • 1 Year change-74.47%
  • Beta0.2619
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers primary solutions, including specialty care management services and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advanced care planning services, as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its administrative services solution includes an integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.

  • Revenue in USD (TTM)2.05bn
  • Net income in USD-180.89m
  • Incorporated2014
  • Employees4.50k
  • Location
    Evolent Health Inc1812 NORTH MOORE ST, SUITE 1705ARLINGTON 22209United StatesUSA
  • Phone+1 (571) 389-6000
  • Fax+1 (571) 389-6001
  • Websitehttps://www.evolent.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.